Molecule Details
InChIKeyHCRKCZRJWPKOAR-JTQLQIEISA-N
Compound NameBrinzolamide
Canonical SMILESCCN[C@H]1CN(CCCOC)S(=O)(=O)c2sc(S(N)(=O)=O)cc21
Clinical Status Clinical Multi-Target
Targets (Human+Pathogen)18
Pfam Stratification Cross-Family
Avg pChEMBL7.67
SourceChEMBL;BindingDB;TTD_MultiTarget
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB01194
Drug NameBrinzolamide
CAS Number138890-62-7
Groups approved investigational
ATC Codes S01EC54 S01EC04 G01AE10
DescriptionBrinzolamide is a highly specific, non-competitive, reversible carbonic anhydrase II (CA-II) inhibitor indicated to reduce ocular pressure in patients with ocular hypertension or open-angle glaucoma.[L35310] Although the exact pathophysiology of glaucoma is still unknown, one of the main hallmarks o...

Categories: Amides Antiglaucoma Preparations and Miotics Carbonic Anhydrase Inhibitors Cytochrome P-450 CYP2A6 Substrates Cytochrome P-450 CYP2B6 Substrates Cytochrome P-450 CYP2C8 Substrates Cytochrome P-450 CYP2C9 Substrates Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 Substrates Diuretics Enzyme Inhibitors Genito Urinary System and Sex Hormones Gynecological Antiinfectives and Antiseptics Ophthalmics Ophthalmologicals Sensory Organs Sulfonamides Sulfones Sulfur Compounds
Cross-references: BindingDB: 10885 ChEBI: 3176 CHEMBL220491 ChemSpider: 62077 Drugs Product Database (DPD): 11799 C07760 D00652 PDB: BZ1 PharmGKB: PA164744929 PubChem:68844 PubChem:46507071 RxCUI: 194881 Therapeutic Targets Database: DAP000602 Wikipedia: Brinzolamide ZINC: ZINC000003953037
Target Activities (18)
Target Gene Organism Category Pfam pChEMBL Type Source
P23280 CA6 Homo sapiens Human PF00194 9.1 Ki ChEMBL;BindingDB
P43166 CA7 Homo sapiens Human PF00194 8.6 Ki ChEMBL;BindingDB
O43570 CA12 Homo sapiens Human PF00194 8.5 Ki ChEMBL;BindingDB
P00918 CA2 Homo sapiens Human PF00194 8.5 Ki ChEMBL;BindingDB
P18505 GABRB1 Homo sapiens Human PF02931 PF02932 8.5 pIC50 TTD_MultiTarget
Q8N1Q1 CA13 Homo sapiens Human PF00194 8.0 Ki ChEMBL;BindingDB
P00915 CA1 Homo sapiens Human PF00194 7.8 Ki ChEMBL;BindingDB
Q9ULX7 CA14 Homo sapiens Human PF00194 7.6 Ki ChEMBL;BindingDB
Q9Y2D0 CA5B Homo sapiens Human PF00194 7.5 Ki ChEMBL;BindingDB
Q16790 CA9 Homo sapiens Human PF00194 7.4 Ki ChEMBL;BindingDB
P22748 CA4 Homo sapiens Human PF00194 7.3 IC50 ChEMBL;BindingDB
P35218 CA5A Homo sapiens Human PF00194 7.3 Ki ChEMBL;BindingDB
Q31FD6 Hydrogenovibrio crunogenus (strain DSM 25203 / XCL-2) Pathogen PF00194 8.4 Ki ChEMBL;BindingDB
Q3I4V7 CAN2 Cryptococcus neoformans Pathogen PF00484 7.1 Ki ChEMBL;BindingDB
P53615 NCE103 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) Pathogen PF00484 6.9 Ki ChEMBL;BindingDB
P9WPJ9 mtcA2 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) Pathogen PF00484 6.9 Ki ChEMBL;BindingDB
O24855 cynT Helicobacter pylori (strain ATCC 700392 / 26695) Pathogen PF00484 6.6 Ki ChEMBL;BindingDB
P9WPJ7 mtcA1 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) Pathogen PF00484 6.1 Ki ChEMBL;BindingDB
DrugBank Target Actions (10)
Target Gene Target Name Action Type
P08684 CYP3A4 Cytochrome P450 3A4 substrate enzymes
P10632 CYP2C8 Cytochrome P450 2C8 substrate enzymes
P11509 CYP2A6 Cytochrome P450 2A6 substrate enzymes
P11712 CYP2C9 Cytochrome P450 2C9 substrate enzymes
P20813 CYP2B6 Cytochrome P450 2B6 substrate enzymes
P00915 CA1 Carbonic anhydrase 1 inhibitor targets
P00918 CA2 Carbonic anhydrase 2 inhibitor targets
P07451 CA3 Carbonic anhydrase 3 inhibitor targets
P22748 CA4 Carbonic anhydrase 4 inhibitor targets
P35218 CA5A Carbonic anhydrase 5A, mitochondrial inhibitor targets